Abstract
Liverworts, widely used as traditional Chinese medicine, are a rich source of structurally diverse secondary metabolites with intriguing biological activities. Given that diterpenoids present in liverwort species possess striking scaffoldings and considering the absence of any previous review on this subject, we present an updated analysis of the diterpenes in liverworts along with their biological activities based on literature dated from 1997 to present. This comprehensive effort is expected to lay the foundation for further research on the diterpenes in liverworts.
Keywords: Diterpenes, liverworts, phytochemistry, classification, structure, bioactivity.
Graphical Abstract
Current Organic Chemistry
Title:Diterpenoids from Liverworts and their Biological Activities
Volume: 22 Issue: 18
Author(s): Na Liu*, Cong Wu, Peng Wang and Hongxiang Lou*
Affiliation:
- Department of Pharmaceutical Engineering, School of Biological Science and Technology, University of Jinan, Jinan,China
- Department of Natural Product Chemistry, Key Laboratory of Chemical Biology (MOE), School of Pharmaceutical Sciences, Shandong University, Jinan,China
Keywords: Diterpenes, liverworts, phytochemistry, classification, structure, bioactivity.
Abstract: Liverworts, widely used as traditional Chinese medicine, are a rich source of structurally diverse secondary metabolites with intriguing biological activities. Given that diterpenoids present in liverwort species possess striking scaffoldings and considering the absence of any previous review on this subject, we present an updated analysis of the diterpenes in liverworts along with their biological activities based on literature dated from 1997 to present. This comprehensive effort is expected to lay the foundation for further research on the diterpenes in liverworts.
Export Options
About this article
Cite this article as:
Liu Na *, Wu Cong , Wang Peng and Lou Hongxiang *, Diterpenoids from Liverworts and their Biological Activities, Current Organic Chemistry 2018; 22 (18) . https://dx.doi.org/10.2174/1385272822666180905112616
DOI https://dx.doi.org/10.2174/1385272822666180905112616 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immune Checkpoint Inhibitors in AML-A New Frontier
Current Cancer Drug Targets MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies
Current Cancer Drug Targets Dibenzofurans from Lichens – A Pharmacological Overview
Current Topics in Medicinal Chemistry An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Anticancer α-Helical Peptides and Structure / Function Relationships Underpinning Their Interactions with Tumour Cell Membranes
Current Protein & Peptide Science New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia
Current Cancer Drug Targets 5q- syndrome
Current Pharmaceutical Design Advances in Translational Pharmacological Investigations in Identifying and Validating Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets HIV-1 Vif: HIVs Weapon Against the Cellular Defense Factor APOBEC3G
Current HIV Research Immunotherapy of Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Twist-BRD4 Complex: Potential Drug Target for Basal-like Breast Cancer
Current Pharmaceutical Design Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Clinical Cancer Drugs Selective Binding BAFF/APRIL by the In and Outside Conservative Region of BCMA
Protein & Peptide Letters HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry Increase in the Non-HIV-Related Deaths Among Aids Cases in the HAART Era
Current HIV Research STAT Inhibition in the Treatment of Cancer: Transcription Factors as Targets for Molecular Therapy
Current Cancer Therapy Reviews Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery